Bisphosphonate-Associated Osteonecrosis of the Jaws: A Guide for the General Dental Practitioner

Barker, Kate; Rogers, Simon

doi:10.12968/denu.2006.33.5.270

Cited by 17 publications

(16 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Osteonecrosis is the jaw (ONJ) is diagnosed clinically as the presence of exposed bone in the maxillofacial region for more than 8 weeks in the absence of radiotherapy to the jaw. 2 As well as more cases, the number of publications related to ONJ has also gone up. A simple search of Medline (search terms: bisphosphonates and osteonecrosis) identifies over 750 papers with about 140 reviews.…”

Section: Commentarymentioning

confidence: 99%

Guidelines for bisphosphonate-associated osteonecrosis of the jaw

Richards¹

2008

Evid Based Dent

View full text Add to dashboard Cite

Scope and purpose This guideline aimed to provide recommendations for the diagnosis of bisphosphonate-associated osteonecrosis of the jaw in both the oncology and osteoporosis patient populations, for dental and medical practitioners including dentists, oral surgeons, oral pathologists, general practitioners and internal medicine specialists. The recommendations are intended to address both prevention and treatment strategies. Methods A consensus-based guideline was developed by a multidisciplinary task force including representatives from national and international societies representing the disciplines of oral surgery, dentistry, oral pathology, oral medicine, endocrinology, rheumatology and oncology. The task force reviewed data collected for a systematic review and prepared discussion papers. The systematic review included searches of Medline, Embase and a manual search of the bibliographies of published articles. A draft guideline was circulated to all members of the task force as well as external experts, and their feedback incorporated into the final document. Recommendations The main recommendations are summarised in Table 1. The task force also recommended that a registry be maintained for all identified cases.

show abstract

Section: Commentarymentioning

confidence: 99%

Guidelines for bisphosphonate-associated osteonecrosis of the jaw

Richards¹

2008

Evid Based Dent

View full text Add to dashboard Cite

show abstract

“…The use of bisphosphonates has been found to be associated with osteonecrosis of the jaw [14]. Bisphosphonates are primary agents in the current pharmacological arsenal against osteoclast-mediated bone loss, because of osteoporosis, OI, and Paget's disease of bone and bone malignancies.…”

Section: Discussionmentioning

confidence: 99%

Dental management of osteogenesis imperfecta

Muhaidib¹,

Mushayt²,

Darwish³

2013

Egyptian Journal of Oral & Maxillofacial Surgery

View full text Add to dashboard Cite

“…Bei einer schweren Minderentwicklung des Unterkiefers sollte besser der Oberkiefer chirurgisch korrigiert und eine Genioplastik durchgeführt werden [28]. [115], " Extraktion von Zähnen, " kieferchirurgische Maßnahmen, " schlecht angepasste zahnmedizinische Apparaturen, " Rauchen " Alkoholabusus Zu den röntgenologischen Anzeichen gehören eine Verbreiterung des Parodontalspaltes im Bereich der Furkation der Molaren und eine wolkige Knochenstruktur als Folge der Osteolyse [115]. [136].…”

Section: Sichelzellanämieunclassified